Cutting Edge: Inhibition of IL-6 <i>Trans</i>-Signaling Protects from Malaria-Induced Lethality in Mice

Claudia M. Wunderlich, Denis Delić, Kristina Behnke, Andreas Meryk, Peter Ströhle, Bhagirath Chaurasia, Saleh Al‐Quraishy, F. Thomas Wunderlich, Jens C. Brüning, F. Thomas Wunderlich

The Journal of Immunology · 2012 · 45 citations · 18 references

DOIFull text

Open access

Concepts

Abstract

Circulating IL-6 levels correlate with the severity of blood-stage malaria in humans and mouse models, but the impact of IL-6 classic signaling through membrane IL-6Rα, as well as IL-6 trans-signaling through soluble IL-6Rα, on the outcome of malaria has remained unknown. In this study, we created IL-6Rα-deficient mice that exhibit a 50% survival of otherwise lethal blood-stage malaria of the genus Plasmodium chabaudi. Inducing IL-6 trans-signaling by injection of mouse recombinant soluble IL-6Rα in IL-6Rα-deficient mice restores the lethal outcome to malaria infection. In contrast, inhibition of IL-6 trans-signaling via injection of recombinant sGP130Fc protein in control mice results in a 40% survival rate. Our data demonstrate that IL-6 trans-signaling, rather than classic IL-6 signaling, contributes to malaria-induced lethality in mice, preceded by an increased inflammatory response. Therefore, inhibition of IL-6 trans-signaling may serve as a novel promising therapeutic basis to combat malaria.

References

18